REQUEST A DEMO
Total
USD $0.00
Search more companies

Emoksifarm AO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Emoksifarm AO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Emoksifarm AO is based in Russia, with the head office in Moscow. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on March 06, 2013. There was a net sales revenue increase of 56.09% reported in Emoksifarm AO’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 66.3%.

Headquarters
Testovskaya, 10, 1/16
Moscow; Moscow; Postal Code: 123112

Contact Details: Purchase the Emoksifarm AO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Emoksifarm AO report to view the information.
Registered Capital:
Purchase the Emoksifarm AO report to view the information.
Incorporation Date:
March 06, 2013
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Emoksifarm AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
56.09%
Total operating revenue
56.09%
Operating profit (EBIT)
39.24%
Net Profit (Loss) for the Period
N/A
Total assets
-66.3%
Total equity
-71.16%
Operating Profit Margin (ROS)
-6.55%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-21.45%
Cash Ratio
-19.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?